bioAffinity Technologies, Inc.
BIAF
$3.83
-$0.17-4.25%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.91M | -14.74M | -11.69M | -9.74M | -9.04M |
| Total Depreciation and Amortization | 504.90K | 534.80K | 572.70K | 610.60K | 605.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.48M | 4.65M | 2.02M | 1.03M | 989.70K |
| Change in Net Operating Assets | 594.20K | 1.11M | 1.42M | 1.53M | 179.70K |
| Cash from Operations | -9.33M | -8.45M | -7.68M | -6.56M | -7.26M |
| Capital Expenditure | -60.60K | -60.60K | -73.60K | -88.50K | -79.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -60.60K | -60.60K | -73.60K | -88.50K | -79.10K |
| Total Debt Issued | -- | -96.90K | 165.00K | 164.10K | 191.80K |
| Total Debt Repaid | -369.80K | -354.10K | -488.20K | -411.60K | -361.10K |
| Issuance of Common Stock | 15.89M | 16.78M | 9.34M | 6.15M | 7.55M |
| Repurchase of Common Stock | -- | -- | -- | -494.90K | -494.90K |
| Issuance of Preferred Stock | 990.00K | 990.00K | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.77M | -1.90M | -1.26M | -766.90K | -1.26M |
| Cash from Financing | 14.73M | 15.42M | 7.75M | 4.64M | 5.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.34M | 6.91M | 1.50K | -2.01M | -1.72M |